Modeling combined transport of water and charged graded-size molecules across the glomerular capillary wall

2010 ◽  
Vol 396 (3) ◽  
pp. 590-595 ◽  
Author(s):  
Ehab I. Mohamed ◽  
Amani M. Bayoumi
1975 ◽  
Vol 51 (3) ◽  
pp. 354-376 ◽  
Author(s):  
Harrison Latta ◽  
William H. Johnston ◽  
Thomas M. Stanley

Nephron ◽  
1992 ◽  
Vol 62 (4) ◽  
pp. 382-388 ◽  
Author(s):  
Alberto Baraldi ◽  
Luciana Furci ◽  
Giovanna Zambruno ◽  
Elisabetta Rubbiani ◽  
Giorgio Annessi ◽  
...  

Author(s):  
Hernán Trimarchi ◽  
Rosanna Coppo

Abstract Immunoglobulin A nephropathy (IgAN) is considered as mesangiopathy since it initiates in the mesangium; however, other glomerular components are involved and the glomerular capillary wall offers the first contact to circulating macromolecular IgA1. Acute and active forms of IgAN are associated with endocapillary hypercellularity and vascular damage of various degrees, in severe cases with microangiopathy (MA) without or with thrombosis [thrombotic microangiopathy (TMA)]. Vascular damage activates complement and coagulation cascades. A defective complement regulation has recently been detected in active and progressive cases of IgAN. C4d deposits in renal biopsies have been found to be an early risk factor. These observations have raised interest in manifestation of MA and TMA in progressive cases of IgAN. MA–TMA lesions have been found in various percentages (2–53%) of patients with IgAN according to patients’ selection and pathology definition of TMA. The association with hypertension (HTN) was so strong that it led to the hypothesis that MA/TMA in IgAN was a mere consequence of severe HTN. Old and new clinical and experimental data indicate that in IgAN the interaction of the glomerular capillary wall with immune reactants and complement uncontrolled activation leading to C4b deposits favours the development of MA–TMA, which plays a role in progression and renal function decline. The central role of complement activation is relevant also for the new therapeutic interventions offered by the pharma.


Sign in / Sign up

Export Citation Format

Share Document